Integrated Filing — IndAS

General information about company
Scrip Code	524735
NSE Symbol	HIKAL
MSEI Symbol	NOTLISTED
ISIN	INE475B01022
Name of company	HIKAL LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	06-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	14-May-2025   11:45:00
End date and time of board meeting	14-May-2025   13:50:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2023-05-29
Indicate Company website link for updated RPT policy of the Company	https://www.hikal.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	Yes

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	5524000000	18598000000
	Other income	5000000	50000000
	Total income	5529000000	18648000000
2	Expenses
(a)	Cost of materials consumed	2107000000	8826000000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	215000000	-453000000
(d)	Employee benefit expense	617000000	2423000000
(e)	Finance costs	179000000	752000000
(f)	Depreciation, depletion and amortisation expense	377000000	1344000000
(f)	Other Expenses
1	Other Expenses	1350000000	4517000000
	Total other expenses	1350000000	4517000000
	Total expenses	4845000000	17409000000
3	Total profit before exceptional items and tax	684000000	1239000000
4	Exceptional items	0	0
5	Total profit before tax	684000000	1239000000
6	Tax expense
7	Current tax	173000000	300000000
8	Deferred tax	8000000	30000000
9	Total tax expenses	181000000	330000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	503000000	909000000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	503000000	909000000
17	Other comprehensive income net of taxes	-10000000	-14000000
18	Total Comprehensive Income for the period	493000000	895000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	247000000	247000000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		12375000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	4.08	7.37
	Diluted earnings (loss) per share from continuing operations	4.08	7.37
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	4.08	7.37
	Diluted earnings (loss) per share from continuing and discontinued operations	4.08	7.37
24	Debt equity ratio	0.0059	0.0059
25	Debt service coverage ratio	0.0145	0.0145
26	Interest service coverage ratio	0.04	0.04
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	13567000000
	Capital work-in-progress	1212000000
	Investment property	0
	Goodwill	0
	Other intangible assets	78000000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	95000000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	215000000
	Total non-current financial assets	310000000
	Deferred tax assets (net)	0
	Other non-current assets	155000000
	Total non-current assets	15322000000
2	Current assets
	Inventories	3345000000
	Current financial asset
	Current investments	0
	Trade receivables, current	5224000000
	Cash and cash equivalents	129000000
	Bank balance other than cash and cash equivalents	50000000
	Loans, current	5000000
	Other current financial assets	655000000
	Total current financial assets	6063000000
	Current tax assets (net)	0
	Other current assets	561000000
	Total current assets	9969000000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	25291000000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	247000000
	Other equity	12375000000
	Total equity attributable to owners of parent	12622000000
	Non controlling interest
	Total equity	12622000000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	3672000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	24000000
	Total non-current financial liabilities	3696000000
	Provisions, non-current	157000000
	Deferred tax liabilities (net)	325000000
	Deferred government grants, Non-current	0
	Other non-current liabilities	593000000
	Total non-current liabilities	4771000000
	Current liabilities
	Current financial liabilities
	Borrowings, current	3951000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	183000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	2859000000
	Total Trade payable	3042000000
	Other current financial liabilities	448000000
	Total current financial liabilities	7441000000
	Other current liabilities	157000000
	Provisions, current	173000000
	Current tax liabilities (Net)	127000000
	Deferred government grants, Current	0
	Total current liabilities	7898000000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	12669000000
	Total equity and liabilites	25291000000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Crop Protection	2011000000	6917000000
2	Pharmaceuticals	3513000000	11681000000
3	Unallocable	0	0
	Total Segment Revenue	5524000000	18598000000
	Less: Inter segment revenue	0	0
	Revenue from operations	5524000000	18598000000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Crop Protection	362000000	792000000
2	Pharmaceuticals	552000000	1374000000
3	Unallocable	0	0
	Total Profit before tax	914000000	2166000000
	i. Finance cost	179000000	179000000
	ii. Other Unallocable Expenditure net off Unallocable income	51000000	51000000
	Profit before tax	684000000	1239000000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Crop Protection	9349000000	9349000000
2	Pharmaceuticals	15393000000	15393000000
3	Unallocable	549000000	549000000
	Total Segment Asset	25291000000	25291000000
	Un-allocable Assets	0	0
	Net Segment Asset	25291000000	25291000000
4	Segment Liabilities
	Segment Liabilities
1	Crop Protection	1262000000	1262000000
2	Pharmaceuticals	2846000000	2846000000
3	Unallocable	8561000000	8561000000
	Total Segment Liabilities	12669000000	12669000000
	Un-allocable Liabilities	0	0
	Net Segment Liabilities	12669000000	12669000000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	12000000	19000000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	-2000000	-5000000
5	Total Other comprehensive income	-10000000	-14000000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1239000000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			752000000
	Adjustments for decrease (increase) in inventories			-324000000
	Adjustments for decrease (increase) in trade receivables, current			235000000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-352000000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			253000000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1344000000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			-100000000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			14000000
	Adjustments for dividend income			0
	Adjustments for interest income			7000000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			48000000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			1863000000
	Net cash flows from (used in) operations			3102000000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			298000000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			2804000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			41000000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			9000000
	Purchase of property, plant and equipment			1373000000
	Proceeds from sales of investment property			4000000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			7000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			29000000
	Net cash flows from (used in) investing activities	-1365000000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			750000000
	Repayments of borrowings			1285000000
	Payments of lease liabilities			3000000
	Dividends paid			148000000
	Interest paid			750000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-1436000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			3000000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			3000000
	Cash and cash equivalents cash flow statement at beginning of period			126000000
	Cash and cash equivalents cash flow statement at end of period			129000000